Coronavirus Covid-19 vaccine update: Oxford-AstraZeneca said that the late-stage date of their Covid-19 vaccine candidate AZD1222-ChAdOx1nCoV-19 would likely to be announced in November or December. (Reuters image)Coronavirus Covid-19 vaccine update:…
Coronavirus, Covid-19 vaccine update: Albert Bourla revealed that a median of two months of safety data following the second and final dose of the Pfizer vaccine candidate will be available…
Coronavirus COVID19 vaccine update, tracker: Oxford-AstraZeneca is still waiting for the US drug regulator to approve the restart of the clinical trial of its potential COVID-19 vaccine in the US.…
Coronavirus COVID-19 Vaccine news, update: Now, Chinese vaccine maker Sinovac Biotech has been mulling to start a human trial of its experimental COVID-19 vaccine candidate with children and adolescents by…
Coronavirus vaccine news, update: Last week Director-General of Indian Council of Medical Research (ICMR) Balram Bhargava told media, "Russia has been manufacturing vaccines for many years. (Reuters image)Coronavirus vaccine news,…
Coronavirus Vaccine latest: Pfizer-BioNTech’s BNT162mRNA vaccine is an mRNA vaccine. (Reuters image)Coronavirus Vaccine latest: The Coronavirus vaccine could be available in the US before the end of this year, claimed American…
Coronavirus vaccine latest update: Back in July this year, Oxford-AstraZeneca’s study had to be stopped for several days after a participant who got the vaccine developed neurological symptoms. (Reuters image)Coronavirus vaccine…
Coronavirus Vaccine: However, apart from Oxford-AstraZenca’s temporary halt, another important event has happened. (Reuters image)Coronavirus Vaccine Latest Update: After the Phase 3 human trial of Oxford-AstraZenca’s Coronavirus vaccine was halted, apprehensions…
Coronavirus Vaccine in India latest update: Russia has so far termed ‘Sputnik V’ as the “first registered vaccine against COVID-19”. (Reuters image)Coronavirus Vaccine in India latest update: Russia has approached the…
Coronavirus vaccine news, update: So far, Phases 1 and 2 human trials of the Russian vaccine have shown a ‘strong’ immune response during clinical trials on 76 people.Coronavirus vaccine news, update:…